Unlock stock picks and a broker-level newsfeed that powers Wall Street.

BSE - Delayed Quote INR

Amrutanjan Health Care Limited (AMRUTANJAN.BO)

692.80
+13.70
+(2.02%)
At close: April 30 at 3:29:15 PM GMT+5:30
Loading Chart for AMRUTANJAN.BO
  • Previous Close 679.10
  • Open 684.00
  • Bid 692.40 x --
  • Ask 699.90 x --
  • Day's Range 558.00 - 708.50
  • 52 Week Range 548.05 - 861.40
  • Volume 21,143
  • Avg. Volume 1,995
  • Market Cap (intraday) 20.021B
  • Beta (5Y Monthly) 0.60
  • PE Ratio (TTM) 40.63
  • EPS (TTM) 17.05
  • Earnings Date May 21, 2025 - May 26, 2025
  • Forward Dividend & Yield 5.60 (0.82%)
  • Ex-Dividend Date Feb 18, 2025
  • 1y Target Est --

Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms and women hygiene products. The company operates through OTC Products, Beverages, and Others segments. It provides pain management products comprising pain balms and roll-ons; and back pain roll-ons, stick-on patch, body pain gels, and joint muscle sprays. The company offers congestion management products that consists of cold rubs, cough syrups, nasal inhalers, and swas mints. It also provides sanitary napkins for women. In addition, the company offers corn caps; dental gel; hand sanitizers; and juice drinks under the Fruitnik and Fruitnik Electro+ brand names, as well as operates a pain management center. It exports its products to the Middle East, Africa, the Southeast Asia, and internationally. The company was formerly known as Amrutanjan Limited and changed its name to Amrutanjan Health Care Limited in 2007. Amrutanjan Health Care Limited was founded in 1893 and is based in Chennai, India.

www.amrutanjan.com

634

Full Time Employees

March 31

Fiscal Year Ends

Recent News: AMRUTANJAN.BO

View More

Performance Overview: AMRUTANJAN.BO

Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

AMRUTANJAN.BO
3.64%
S&P BSE SENSEX (^BSESN)
2.69%

1-Year Return

AMRUTANJAN.BO
0.10%
S&P BSE SENSEX (^BSESN)
7.73%

3-Year Return

AMRUTANJAN.BO
21.78%
S&P BSE SENSEX (^BSESN)
40.63%

5-Year Return

AMRUTANJAN.BO
82.69%
S&P BSE SENSEX (^BSESN)
137.98%

Compare To: AMRUTANJAN.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AMRUTANJAN.BO

View More

Valuation Measures

Annual
As of 4/29/2025
  • Market Cap

    19.62B

  • Enterprise Value

    17.35B

  • Trailing P/E

    39.85

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.44

  • Price/Book (mrq)

    6.59

  • Enterprise Value/Revenue

    3.92

  • Enterprise Value/EBITDA

    23.28

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    11.12%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    4.44B

  • Net Income Avi to Common (ttm)

    493.16M

  • Diluted EPS (ttm)

    17.05

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.29B

  • Total Debt/Equity (mrq)

    0.74%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: AMRUTANJAN.BO

View More

Company Insights: AMRUTANJAN.BO

Research Reports: AMRUTANJAN.BO

View More

People Also Watch